Skip to main content

Table 4 T lymphocyte profile of Olmsted syndrome case and age-matched healthy controls

From: Olmsted syndrome: exploration of the immunological phenotype

Subset

Defining surface markers

Patient (%)

Healthy volunteers (%)

 
   

Mean (SD)

Median (min-max)

T cells

CD3+

25.0

21.7 (10.7)

20.2 (8.48-41.6)

CD4 + subsets

    

CD4+ T cells

CD4+CD8-

18.2

11.0 (6.03)

7.79 (3.82-19.9)

 →Treg

Foxp3+

1.91

3.67 (2.52)

2.97 (1.54-9.37)

 →Th1

IFNγ+

1.22

3.18 (1.57)

3.36 (0.96-5.28)

 →Th2

IL-4+

2.14

5.03 (2.45)

5.12 (1.90-11.0)

 →Th17

IL-17+

0.08

0.05 (0.04)

0.03 (0–0.1)

 →IL-2+

IL-2+

1.69

2.25 (1.06)

2.67 (0.95-4.11)

 →Tfh

CD45RA-CXCR5+

0.59

0.14 (0.11)

0.11 (0.026-0.41)

 →Naïve

CD45RA+CCR7+

61.3

44.1 (9.73)

43.6 (31.0-58.4)

 →RTE

CD45RA+CCR7+CD31+

46.3

35.6 (8.77)

35.7 (22.8-49.7)

 →TCM

CD45RA-CCR7+

14.6

12.2 (4.24)

11.6 (6.36-18.7)

 →TEM

CD45RA-CCR7-

15.6

32.5 (7.54)

35.2 (21.0-43.7)

 →TEMRA

CD45RA+CCR7-

8.50

11.9 (5.55)

7.78 (6.52-21.2)

CD8 + subsets

    

CD8+ T cells

CD4-CD8+

7.75

9.51 (4.12)

8.64 (4.45-17.5)

 →IFNγ+

IFNγ+

8.1

23.3 (9.09)

19.9 (12.7-40.0)

 →IL-2+

IL-2+

1.48

3.46 (1.74)

2.82 (1.78-7.17)

 →Naïve

CD45RA+CCR7+

60.9

41.2 (13.9)

37.4 (26.3-62.2)

 →RTE

CD45RA+CCR7+CD31+

59.0

38.2 (14.0)

32.3 (24.0-60.0)

 →TCM

CD45RA-CCR7+

3.08

3.11 (1.52)

2.91 (1.08-6.00)

 →TEM

CD45RA-CCR7-

16.0

24.1 (7.63)

22.0 (14.8-41.3)

 →TEMRA

CD45RA+CCR7-

20.1

31.6 (12.5)

31.2 (15.3-49.9)

  1. The frequency of CD3+ cells is shown as percentage from all leukocytes. CD4+ subsets and CD8+ subsets are from percentage CD4+ and CD8+ respectively.